ArticlePituitary2021

Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients.

Filippo Ceccato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.